MAUREEN OCONNELL
CIK 1111318 · EVP, CAO & CFO · last filed 2026-08-20
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$5.18M
Companies
6
Total Filings
96
Lifetime Open-Market Net
-$19.81M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ACTG | Director | 287,655 | $4.51 | $1.30M | $48.5K | 11 | 2026-08-20 |
| TEX | Director | 16,351 | $62.76 | $1.03M | $0 | 2 | 2026-03-09 |
| REV Group, Inc. (REVG) Delisted | Director | 2,105 | $63.90 | $134.5K | $0 | 5 | 2026-02-02 |
| HHS | Director | 25,414 | $4.21 | $107.0K | $0 | 3 | 2020-09-02 |
| Sucampo Pharmaceuticals, Inc. (SCMP) Delisted | Director | 0 | — | — | $0 | 6 | 2018-02-13 |
| SCHL | EVP, CAO & CFO | 71,771 | $38.32 | $2.75M | -$19.86M | 68 | 2017-09-26 |
Recent Filings · Page 2 of 10
96 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-12-12 | REV Group, Inc. (REVG) Delisted | Grant (A) | +7,084 | $0 | EDGAR |
| 2023-08-29 | REV Group, Inc. (REVG) Delisted | Grant (A) | +2,739 | $0 | EDGAR |
| 2023-05-31 | ACTG | Grant (A) | +30,534 | $0 | EDGAR |
| 2022-05-11 | ACTG | Grant (A) | +26,201 | $0 | EDGAR |
| 2021-05-12 | ACTG | Grant (A) | +21,661 | $0 | EDGAR |
| 2020-09-08 | ACTG | Buy (P) | +25,000 | $94.5K | EDGAR |
| 2020-09-02 | HHS | Exer (M) | +27,693 | $0 | EDGAR |
| 2020-06-04 | ACTG | Grant (A) | +48,000 | $0 | EDGAR |
| 2019-08-01 | ACTG | Grant (A) | +43,478 | $0 | EDGAR |
| 2019-05-13 | ACTG | Grant (A) | +22,436 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.